June 10, 2016
Mitsubishi Gas Chemical and Nippon Kayaku said on June 8 that they have set up a joint venture in Japan for the manufacturing of monoclonal antibodies including biosimilars. Capitalized at 50 million yen, the new firm, Cultivecs Inc., will be...read more